Clinical Applications of ctDNA Testing and Introducing New Indications

28 Jan 2026
Cancer Diagnostics Stage
  • Matching patients to clinical trials based on their ctDNA 

  • Adding new liquid biopsy indications onto the national test directory.  

  • Advantages of liquid biopsies compared to current gold standards.  

  • Epigenetic biomarkers and future directions. 

Speakers
Matthew Krebs
Matthew Krebs, Cancer Medical Lead - North West Genomic Laboratory Hub